Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Dr Reddy’s Laboratories ( (RDY) ) has shared an announcement.
On February 11, 2025, Dr. Reddy’s Laboratories announced its participation in a series of investor conferences organized by Investec. These meetings are scheduled to take place in Abu Dhabi and Dubai on February 17 and 18, 2025, and will be conducted in-person with various investor groups. This engagement highlights Dr. Reddy’s proactive approach in maintaining transparency with stakeholders and reinforcing its position in the global pharmaceutical market.
More about Dr Reddy’s Laboratories
Dr. Reddy’s Laboratories Limited is a prominent player in the pharmaceutical industry, based in Hyderabad, India. The company specializes in the development, manufacturing, and marketing of a wide range of pharmaceutical products, with a strong focus on generic medications, active pharmaceutical ingredients (APIs), and over-the-counter (OTC) products. Dr. Reddy’s is listed on major stock exchanges including the National Stock Exchange of India, BSE Limited, New York Stock Exchange, and NSE IFSC, reflecting its significant market presence and global reach.
YTD Price Performance: -11.87%
Average Trading Volume: 1,702,624
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $11.75B
For detailed information about RDY stock, go to TipRanks’ Stock Analysis page.
